醫藥品研究受託製造(CRAM)的全球市場 2023-2027

醫藥品研究受託製造(CRAM)市場在2022年～2027年間預計將以年複合成長率10.32％增長到1213億5000萬美元。

本報告提供醫藥品研究受託製造(CRAM)市場整體分析，提供市場規模與預測，趨勢，成長促進因素，網羅了課題，再加上約25家供應商的供應商分析。

本報告提供同時本報告還提供當前全球市場趨勢與推動因素以及整體市場環境的最新分析。市場成長的主要因素有新興市場上高成本效益資源的可利用性，集中核心競爭力的需求提升，強力研究資金。

目錄

第1章 摘要整理

• 市場概要

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 市場區隔分析
• 市場規模 2022
• 市場預測:2022-2027年的預測

第4章 市場規模實際成果

• 全球醫藥品研究受託製造(CRAM)市場2017年-2021年
• 服務市場區隔分析2017-2021
• 終端用戶市場區隔分析2017-2021
• 地區市場區隔分析2017-2021
• 國家市場區隔分析2017-2021

第5章 波特的五力分析

• 五力的摘要
• 買方議價能力
• 供給企業談判力
• 新加入廠商業者的威脅
• 替代品的威脅
• 競爭的威脅
• 市場情況

第6章 各類服務市場區隔

• 市場·市場區隔
• 各類服務比較
• CMO - 市場規模與預測 2022-2027
• CRO - 市場規模與預測 2022-2027
• 各類服務的市場機會

第7章 各終端用戶市場區隔

• 市場·市場區隔
• 各終端用戶比較
• 大醫藥品 - 市場規模與預測 2022-2027
• 中小醫藥品 - 市場規模與預測 2022-2027
• 學名藥 - 市場規模與預測 2022-2027
• 各終端用戶的市場機會

第8章 客戶形勢

• 客戶形勢概要

第9章 各地區形勢

• 各地區市場區隔
• 各地區比較
• 北美 - 市場規模與預測 2022-2027
• 亞洲 - 市場規模與預測 2022-2027
• 歐洲 - 市場規模與預測 2022-2027
• 其他地區(ROW) - 市場規模與預測 2022-2027
• 美國 - 市場規模與預測 2022-2027
• 印度 - 市場規模與預測 2022-2027
• 中國 - 市場規模與預測 2022-2027
• 德國 - 市場規模與預測 2022-2027
• 英國 - 市場規模與預測 2022-2027
• 各地區形勢的市場機會

第10章 促進因素，課題，及趨勢

• 推動市場要素
• 市場課題
• 推動因素與課題的影響
• 市場趨勢

第11章 業者情勢

• 概要
• 業者情勢
• 混亂狀況
• 產業的風險

第12章 供應商分析

• 交易廠商
• 供應商的市場定位
• Almac Group Ltd.
• Boehringer Ingelheim International GmbH
• Cadila Pharmaceuticals Ltd.
• Catalent Inc.
• Charles River Laboratories International Inc.
• Cmic Holdings Co. Ltd.
• Dr Reddys Laboratories Ltd.
• ICON plc
• IQVIA Holdings Inc.
• Laboratory Corp. of America Holdings
• Lonza Group Ltd.
• Lupin Ltd.
• Recipharm AB
• Samsung Electronics Co. Ltd.
• Syneos Health Inc.

第13章 附錄

Technavio has been monitoring the pharmaceutical contract research and manufacturing (CRAM) market and is forecast to grow by $ 121.35 bn during 2022-2027, accelerating at a CAGR of 10.32% during the forecast period. Our report on the pharmaceutical contract research and manufacturing (CRAM) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the availability of cost-efficient resources in emerging markets, the growing need to focus on core competencies, and strong research funding.

Technavio's pharmaceutical contract research and manufacturing (CRAM) market is segmented as below:

By Service

• CMO
• CRO

By End-user

• Big pharmaceuticals
• Small and medium-sized pharmaceuticals
• Generic pharmaceuticals

By Geographical Landscape

• North America
• Asia
• Europe
• Rest of World (ROW)

This study identifies the increasing number of us FDA-approved manufacturing facilities as one of the prime reasons driving the pharmaceutical contract research and manufacturing (CRAM) market growth during the next few years. Also, the increasing number of patent expiration of drugs and the advent of big data will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the pharmaceutical contract research and manufacturing (CRAM) market covers the following areas:

• Pharmaceutical contract research and manufacturing (CRAM) market sizing
• Pharmaceutical contract research and manufacturing (CRAM) market forecast
• Pharmaceutical contract research and manufacturing (CRAM) market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical contract research and manufacturing (CRAM) market vendors that include Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Catalent Inc., Charles River Laboratories International Inc., Cmic Holdings Co. Ltd., Dr Reddys Laboratories Ltd., ICON plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Lonza Group Ltd., Lupin Ltd., Recipharm AB, Samsung Electronics Co. Ltd., Syneos Health Inc., Thermo Fisher Scientific Inc., PCI Pharma Services, Parexel International Corp., OPTIMAPHARM d.o.o., and Novotech Australia Pty Ltd. Also, the pharmaceutical contract research and manufacturing (CRAM) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Service
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global pharmaceutical contract research and manufacturing (CRAM) market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global pharmaceutical contract research and manufacturing (CRAM) market 2017 - 2021 ($ billion)
• 4.2 Service Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Service Segment 2017 - 2021 ($ billion)
• 4.3 End-user Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Service

• 6.1 Market segments
• Exhibit 30: Chart on Service - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Service - Market share 2022-2027 (%)
• 6.2 Comparison by Service
• Exhibit 32: Chart on Comparison by Service
• Exhibit 33: Data Table on Comparison by Service
• 6.3 CMO - Market size and forecast 2022-2027
• Exhibit 34: Chart on CMO - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on CMO - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on CMO - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on CMO - Year-over-year growth 2022-2027 (%)
• 6.4 CRO - Market size and forecast 2022-2027
• Exhibit 38: Chart on CRO - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on CRO - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on CRO - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on CRO - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Service
• Exhibit 42: Market opportunity by Service ($ billion)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
• 7.2 Comparison by End-user
• Exhibit 45: Chart on Comparison by End-user
• Exhibit 46: Data Table on Comparison by End-user
• 7.3 Big pharmaceuticals - Market size and forecast 2022-2027
• Exhibit 47: Chart on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibit 48: Data Table on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibit 49: Chart on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
• 7.4 Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027
• Exhibit 51: Chart on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibit 52: Data Table on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibit 53: Chart on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
• 7.5 Generic pharmaceuticals - Market size and forecast 2022-2027
• Exhibit 55: Chart on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibit 56: Data Table on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibit 57: Chart on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
• 7.6 Market opportunity by End-user
• Exhibit 59: Market opportunity by End-user ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 63: Chart on Geographic comparison
• Exhibit 64: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Asia - Market size and forecast 2022-2027
• Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.5 Europe - Market size and forecast 2022-2027
• Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 India - Market size and forecast 2022-2027
• Exhibit 85: Chart on India - Market size and forecast 2022-2027 ($ billion)
• Exhibit 86: Data Table on India - Market size and forecast 2022-2027 ($ billion)
• Exhibit 87: Chart on India - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on India - Year-over-year growth 2022-2027 (%)
• 9.9 China - Market size and forecast 2022-2027
• Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.10 Germany - Market size and forecast 2022-2027
• Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.11 UK - Market size and forecast 2022-2027
• Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 101: Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 102: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 104: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 105: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 106: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 107: Matrix on vendor position and classification
• 12.3 Almac Group Ltd.
• Exhibit 108: Almac Group Ltd. - Overview
• Exhibit 109: Almac Group Ltd. - Product / Service
• Exhibit 110: Almac Group Ltd. - Key offerings
• 12.4 Boehringer Ingelheim International GmbH
• Exhibit 111: Boehringer Ingelheim International GmbH - Overview
• Exhibit 112: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 113: Boehringer Ingelheim International GmbH - Key news
• Exhibit 114: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 115: Boehringer Ingelheim International GmbH - Segment focus
• 12.5 Cadila Pharmaceuticals Ltd.
• Exhibit 116: Cadila Pharmaceuticals Ltd. - Overview
• Exhibit 117: Cadila Pharmaceuticals Ltd. - Product / Service
• Exhibit 118: Cadila Pharmaceuticals Ltd. - Key offerings
• 12.6 Catalent Inc.
• Exhibit 119: Catalent Inc. - Overview
• Exhibit 120: Catalent Inc. - Business segments
• Exhibit 121: Catalent Inc. - Key news
• Exhibit 122: Catalent Inc. - Key offerings
• Exhibit 123: Catalent Inc. - Segment focus
• 12.7 Charles River Laboratories International Inc.
• Exhibit 124: Charles River Laboratories International Inc. - Overview
• Exhibit 125: Charles River Laboratories International Inc. - Business segments
• Exhibit 126: Charles River Laboratories International Inc. - Key news
• Exhibit 127: Charles River Laboratories International Inc. - Key offerings
• Exhibit 128: Charles River Laboratories International Inc. - Segment focus
• 12.8 Cmic Holdings Co. Ltd.
• Exhibit 129: Cmic Holdings Co. Ltd. - Overview
• Exhibit 130: Cmic Holdings Co. Ltd. - Business segments
• Exhibit 131: Cmic Holdings Co. Ltd. - Key offerings
• Exhibit 132: Cmic Holdings Co. Ltd. - Segment focus
• 12.9 Dr Reddys Laboratories Ltd.
• Exhibit 133: Dr Reddys Laboratories Ltd. - Overview
• Exhibit 134: Dr Reddys Laboratories Ltd. - Business segments
• Exhibit 135: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibit 136: Dr Reddys Laboratories Ltd. - Segment focus
• 12.10 ICON plc
• Exhibit 137: ICON plc - Overview
• Exhibit 138: ICON plc - Product / Service
• Exhibit 139: ICON plc - Key offerings
• 12.11 IQVIA Holdings Inc.
• Exhibit 140: IQVIA Holdings Inc. - Overview
• Exhibit 141: IQVIA Holdings Inc. - Business segments
• Exhibit 142: IQVIA Holdings Inc. - Key news
• Exhibit 143: IQVIA Holdings Inc. - Key offerings
• Exhibit 144: IQVIA Holdings Inc. - Segment focus
• 12.12 Laboratory Corp. of America Holdings
• Exhibit 145: Laboratory Corp. of America Holdings - Overview
• Exhibit 146: Laboratory Corp. of America Holdings - Business segments
• Exhibit 147: Laboratory Corp. of America Holdings - Key news
• Exhibit 148: Laboratory Corp. of America Holdings - Key offerings
• Exhibit 149: Laboratory Corp. of America Holdings - Segment focus
• 12.13 Lonza Group Ltd.
• Exhibit 150: Lonza Group Ltd. - Overview
• Exhibit 151: Lonza Group Ltd. - Business segments
• Exhibit 152: Lonza Group Ltd. - Key news
• Exhibit 153: Lonza Group Ltd. - Key offerings
• Exhibit 154: Lonza Group Ltd. - Segment focus
• 12.14 Lupin Ltd.
• Exhibit 155: Lupin Ltd. - Overview
• Exhibit 156: Lupin Ltd. - Product / Service
• Exhibit 157: Lupin Ltd. - Key news
• Exhibit 158: Lupin Ltd. - Key offerings
• 12.15 Recipharm AB
• Exhibit 159: Recipharm AB - Overview
• Exhibit 160: Recipharm AB - Business segments
• Exhibit 161: Recipharm AB - Key offerings
• Exhibit 162: Recipharm AB - Segment focus
• 12.16 Samsung Electronics Co. Ltd.
• Exhibit 163: Samsung Electronics Co. Ltd. - Overview
• Exhibit 164: Samsung Electronics Co. Ltd. - Business segments
• Exhibit 165: Samsung Electronics Co. Ltd. - Key news
• Exhibit 166: Samsung Electronics Co. Ltd. - Key offerings
• Exhibit 167: Samsung Electronics Co. Ltd. - Segment focus
• 12.17 Syneos Health Inc.
• Exhibit 168: Syneos Health Inc. - Overview
• Exhibit 169: Syneos Health Inc. - Business segments
• Exhibit 170: Syneos Health Inc. - Key offerings
• Exhibit 171: Syneos Health Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 172: Inclusions checklist
• Exhibit 173: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 174: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 175: Research methodology
• Exhibit 176: Validation techniques employed for market sizing
• Exhibit 177: Information sources
• 13.5 List of abbreviations
• Exhibit 178: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Service
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global pharmaceutical contract research and manufacturing (CRAM) market 2017 - 2021 ($ billion)
• Exhibits19: Historic Market Size - Service Segment 2017 - 2021 ($ billion)
• Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Service - Market share 2022-2027 (%)
• Exhibits31: Data Table on Service - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Service
• Exhibits33: Data Table on Comparison by Service
• Exhibits34: Chart on CMO - Market size and forecast 2022-2027 ($ billion)
• Exhibits35: Data Table on CMO - Market size and forecast 2022-2027 ($ billion)
• Exhibits36: Chart on CMO - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on CMO - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on CRO - Market size and forecast 2022-2027 ($ billion)
• Exhibits39: Data Table on CRO - Market size and forecast 2022-2027 ($ billion)
• Exhibits40: Chart on CRO - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on CRO - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Service ($ billion)
• Exhibits43: Chart on End-user - Market share 2022-2027 (%)
• Exhibits44: Data Table on End-user - Market share 2022-2027 (%)
• Exhibits45: Chart on Comparison by End-user
• Exhibits46: Data Table on Comparison by End-user
• Exhibits47: Chart on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibits48: Data Table on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibits49: Chart on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
• Exhibits50: Data Table on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
• Exhibits51: Chart on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibits52: Data Table on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibits53: Chart on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
• Exhibits54: Data Table on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
• Exhibits55: Chart on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibits56: Data Table on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
• Exhibits57: Chart on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
• Exhibits58: Data Table on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
• Exhibits59: Market opportunity by End-user ($ billion)
• Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits63: Chart on Geographic comparison
• Exhibits64: Data Table on Geographic comparison
• Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits75: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on India - Market size and forecast 2022-2027 ($ billion)
• Exhibits86: Data Table on India - Market size and forecast 2022-2027 ($ billion)
• Exhibits87: Chart on India - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on India - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits91: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits101: Market opportunity By Geographical Landscape ($ billion)
• Exhibits102: Impact of drivers and challenges in 2022 and 2027
• Exhibits103: Overview on Criticality of inputs and Factors of differentiation
• Exhibits104: Overview on factors of disruption
• Exhibits105: Impact of key risks on business
• Exhibits106: Vendors covered
• Exhibits107: Matrix on vendor position and classification
• Exhibits108: Almac Group Ltd. - Overview
• Exhibits109: Almac Group Ltd. - Product / Service
• Exhibits110: Almac Group Ltd. - Key offerings
• Exhibits111: Boehringer Ingelheim International GmbH - Overview
• Exhibits112: Boehringer Ingelheim International GmbH - Business segments
• Exhibits113: Boehringer Ingelheim International GmbH - Key news
• Exhibits114: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits115: Boehringer Ingelheim International GmbH - Segment focus
• Exhibits116: Cadila Pharmaceuticals Ltd. - Overview
• Exhibits117: Cadila Pharmaceuticals Ltd. - Product / Service
• Exhibits118: Cadila Pharmaceuticals Ltd. - Key offerings
• Exhibits119: Catalent Inc. - Overview
• Exhibits120: Catalent Inc. - Business segments
• Exhibits121: Catalent Inc. - Key news
• Exhibits122: Catalent Inc. - Key offerings
• Exhibits123: Catalent Inc. - Segment focus
• Exhibits124: Charles River Laboratories International Inc. - Overview
• Exhibits125: Charles River Laboratories International Inc. - Business segments
• Exhibits126: Charles River Laboratories International Inc. - Key news
• Exhibits127: Charles River Laboratories International Inc. - Key offerings
• Exhibits128: Charles River Laboratories International Inc. - Segment focus
• Exhibits129: Cmic Holdings Co. Ltd. - Overview
• Exhibits130: Cmic Holdings Co. Ltd. - Business segments
• Exhibits131: Cmic Holdings Co. Ltd. - Key offerings
• Exhibits132: Cmic Holdings Co. Ltd. - Segment focus
• Exhibits133: Dr Reddys Laboratories Ltd. - Overview
• Exhibits134: Dr Reddys Laboratories Ltd. - Business segments
• Exhibits135: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibits136: Dr Reddys Laboratories Ltd. - Segment focus
• Exhibits137: ICON plc - Overview
• Exhibits138: ICON plc - Product / Service
• Exhibits139: ICON plc - Key offerings
• Exhibits140: IQVIA Holdings Inc. - Overview
• Exhibits141: IQVIA Holdings Inc. - Business segments
• Exhibits142: IQVIA Holdings Inc. - Key news
• Exhibits143: IQVIA Holdings Inc. - Key offerings
• Exhibits144: IQVIA Holdings Inc. - Segment focus
• Exhibits145: Laboratory Corp. of America Holdings - Overview
• Exhibits146: Laboratory Corp. of America Holdings - Business segments
• Exhibits147: Laboratory Corp. of America Holdings - Key news
• Exhibits148: Laboratory Corp. of America Holdings - Key offerings
• Exhibits149: Laboratory Corp. of America Holdings - Segment focus
• Exhibits150: Lonza Group Ltd. - Overview
• Exhibits151: Lonza Group Ltd. - Business segments
• Exhibits152: Lonza Group Ltd. - Key news
• Exhibits153: Lonza Group Ltd. - Key offerings
• Exhibits154: Lonza Group Ltd. - Segment focus
• Exhibits155: Lupin Ltd. - Overview
• Exhibits156: Lupin Ltd. - Product / Service
• Exhibits157: Lupin Ltd. - Key news
• Exhibits158: Lupin Ltd. - Key offerings
• Exhibits159: Recipharm AB - Overview
• Exhibits160: Recipharm AB - Business segments
• Exhibits161: Recipharm AB - Key offerings
• Exhibits162: Recipharm AB - Segment focus
• Exhibits163: Samsung Electronics Co. Ltd. - Overview
• Exhibits164: Samsung Electronics Co. Ltd. - Business segments
• Exhibits165: Samsung Electronics Co. Ltd. - Key news
• Exhibits166: Samsung Electronics Co. Ltd. - Key offerings
• Exhibits167: Samsung Electronics Co. Ltd. - Segment focus
• Exhibits168: Syneos Health Inc. - Overview
• Exhibits169: Syneos Health Inc. - Business segments
• Exhibits170: Syneos Health Inc. - Key offerings
• Exhibits171: Syneos Health Inc. - Segment focus
• Exhibits172: Inclusions checklist
• Exhibits173: Exclusions checklist
• Exhibits174: Currency conversion rates for US$
• Exhibits175: Research methodology
• Exhibits176: Validation techniques employed for market sizing
• Exhibits177: Information sources
• Exhibits178: List of abbreviations